Crossmark

Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder

Crossref DOI link: https://doi.org/10.1038/s41386-022-01344-y

Published Online: 2022-06-03

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

D’Souza, Deepak Cyril https://orcid.org/0000-0003-3141-1462
Syed, Shariful A.

Flynn, L. Taylor

Safi-Aghdam, Hamideh

Cozzi, Nicholas V.

Ranganathan, Mohini
Funding

Funding for this research was provided by:

Wallace Foundation
License Information

Text and Data Mining valid from 2022-06-03

Version of Record valid from 2022-06-03
More Information

Article History

Received: 29 January 2022

Revised: 3 May 2022

Accepted: 5 May 2022

First Online: 3 June 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below